These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3042644)

  • 1. Randomized double-blind study of flunarizine versus placebo in patients with chronic cerebrovascular disorders.
    Agnoli A; Manna V; Martucci N; Fioravanti M; Ferromilone F; Cananzi A; D'Andrea G; De Rosa A; Vizioli R; Sinforiani E
    Int J Clin Pharmacol Res; 1988; 8(3):189-97. PubMed ID: 3042644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical double blind study with the calcium antagonist flunarizine cerebral circulatory disturbances].
    Eckmann F
    Arzneimittelforschung; 1985; 35(8):1276-9. PubMed ID: 3907638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of the effects of citicoline in chronic cerebrovascular diseases].
    Sinforiani E; Trucco M; Pacchetti C; Gualtieri S
    Minerva Med; 1986 Jan; 77(1-2):51-7. PubMed ID: 3511406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flunarizine and betahistine. Two different therapeutic approaches in vertigo compared in a double-blind study.
    Elbaz P
    Acta Otolaryngol Suppl; 1988; 460():143-8. PubMed ID: 3074614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flunarizine as add-on therapy in epilepsy. Crossover study vs placebo.
    Moglia A; Bergamasco B; Di Perri R; Mancia D
    Funct Neurol; 1986; 1(4):547-50. PubMed ID: 3301560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Use of a new preparation of flunarizine in patients with peripheral obliterating arteriopathy at the second stage. Controlled clinical study].
    Guerrini M; Pieragalli D; De Franco V; Di Perri T
    Clin Ter; 1989 Jun; 129(6):445-58. PubMed ID: 2526706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects induced by vincamine teprosilate on chronic cerebrovascular disease: preliminary results.
    Lanfranchi M; Magnani G; Sinforiani E; Casali R
    Int J Clin Pharmacol Res; 1984; 4(4):307-12. PubMed ID: 6389380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flunarizine in alternating hemiplegia in childhood. An international study in 12 children.
    Casaer P
    Neuropediatrics; 1987 Nov; 18(4):191-5. PubMed ID: 3320807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Whole blood filterability in chronic cerebrovascular disorders: effects of the use of buflomedil hydrochloride].
    Ciuffetti G; Mercuri M; Lombardini R; Palazzetti D; Rizzo MT; Parnetti L
    Minerva Med; 1989 Nov; 80(11):1237-40. PubMed ID: 2689916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effectiveness of flunarizine in the prophylaxis of migraine: a meta-analytical review of the literature].
    Reveiz-Herault L; Cardona AF; Ospina EG; Carrillo P
    Rev Neurol; 2003 May 16-31; 36(10):907-12. PubMed ID: 12766861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Valproate versus flunarizine in migraine prophylaxis: a randomized, double-open, clinical trial.
    Mitsikostas DD; Polychronidis I
    Funct Neurol; 1997; 12(5):267-76. PubMed ID: 9439944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Betahistine dihydrochloride versus flunarizine. A double-blind study on recurrent vertigo with or without cochlear syndrome typical of Menière's disease.
    Fraysse B; Bebear JP; Dubreuil C; Berges C; Dauman R
    Acta Otolaryngol Suppl; 1991; 490():1-10. PubMed ID: 1763646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of post-phlebitic syndrome and venous leg ulcers with flunarizine.
    Nikolova K
    Methods Find Exp Clin Pharmacol; 1994 Oct; 16(8):609-13. PubMed ID: 7760586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prevention of migraine using flunarizine (results of a pilot study using Amalium)].
    Wessely P; Holzner F
    Wien Med Wochenschr; 1987 Jan; 137(1):21-6. PubMed ID: 3590812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclandelate versus flunarizine. A double-blind study in a selected group of patients with dementia.
    Albizzati MG; Bassi S; Calloni E; Sbacchi M; Piolti R; Frattola L
    Drugs; 1987; 33 Suppl 2():90-6. PubMed ID: 3304956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Flunarizine--a new agent for migraine prevention. Results of a double-blind comparison with placebo].
    Frenken CW; Nuijten ST
    Fortschr Med; 1984 Mar; 102(12):349-51. PubMed ID: 6370811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The velocity step test. Its use in the evaluation of the effects of drugs in dizzy patients.
    Theunissen EJ; Huygen PL; Folgering HT; Nicolasen MG
    Acta Otolaryngol Suppl; 1988; 460():104-13. PubMed ID: 3074608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A double-blind controlled clinical study on the use of mucopolysaccharides in the treatment of patients with cerebral vasculopathy. Comparison with a placebo].
    Bardin P; Campo R
    Clin Ter; 1987 Jan; 120(2):111-8. PubMed ID: 2972439
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical evaluation of GABA in the treatment of cerebrovascular disorders. Multi-center double-blind study in comparison with pyrithioxine and placebo.
    Otomo E; Araki G; Mori A; Kurihara M
    Arzneimittelforschung; 1981; 31(9):1511-23. PubMed ID: 7030354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vertigo, particularly of vascular origin, treated with flunarizine (R 14 950).
    Boniver R
    Arzneimittelforschung; 1978; 28(10):1800-4. PubMed ID: 582686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.